SCHEMBL6711745

SCHEMBL6711745

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)Cc4ccccc4C(F)(F)F)c3[nH]2)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 1/20 0.38
CETP P11597 1/20 0.36
PARP14 Q460N5 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
RXFP1 Q9HBX9 1/20 0.34
BRD4 O60885 1/20 0.34
HDAC1 Q13547 1/20 0.34
HTT P42858 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ANO1 Q5XXA6 2/20 0.33
AKT1 P31749 1/20 0.32
ALDH1A1 P00352 1/20 0.32
BRAF P15056 1/20 0.32
KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710182 0.90 ALDH1A1 (0.40) PLA2G7PARP14KMT2AMEN1HDAC1
SCHEMBL6707901 0.89 PARP14 (0.40) PLA2G7PARP14BRD4HDAC1ANO1
SCHEMBL6708561 0.89 NSD2 (0.39) PLA2G7CETPPARP14KMT2AMEN1
SCHEMBL6708826 0.89 PLA2G7 (0.39) PLA2G7KMT2AMEN1BRD4HDAC1
SCHEMBL6710326 0.89 GAA (0.40) PLA2G7KMT2AMEN1HTTNPC1
SCHEMBL6713683 0.89 PARP14 (0.37) PARP14RXFP1BRD4HDAC1KDR
SCHEMBL6709308 0.88 TP53 (0.41) PLA2G7KMT2AMEN1HDAC1TSHR
SCHEMBL6709207 0.88 PARP14 (0.43) PLA2G7PARP14HDAC1ALDH1A1
SCHEMBL6708747 0.87 PARP14 (0.43) PARP14KMT2AMEN1RXFP1BRAF
SCHEMBL6710395 0.87 PKM (0.35) PLA2G7PARP14RXFP1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PLA2G7 3314/4885CETP 4517/4885PARP14 2597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.